TY - JOUR
T1 - Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide
AU - Ehlert, F. J.
AU - Roeske, W. R.
AU - Yamamura, H. I.
PY - 1980
Y1 - 1980
N2 - The regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide (NEM) was investigated using the agonist ligand, [3H] cis methyldioxolane ([3H]CD). Characterization studies on rat forebrain homogenates showed that [3H]CD binding was linear with tissue concentration and was unaffected by a change in pH form 5.5 to 8.0. The regional variation in [3H]CD binding in the rat brain correlated generally with [3H](-)3-quinuclidinyl benzilate ([3H](-)QNB) binding, although the absolute variation in binding was somewhat less. At a concentration of 100 μM, the GTP analogue, guanyl-5'-yl imidodiphosphate [Gpp(NH)p], caused a 43-77% inhibition of [3H]CD binding in the corpus striatum, ileum, and heart. The results of binding studies using several Gpp(NH)p concentrations demonstrated that the potency of this guanine nucleotide for inhibition of [3H]CD binding was greater in the heart than in the ileum. In contrast to its effects on [3H]CD binding, Gpp(NH)p caused an increase in [3H](-)QNB binding in the heart and ileum and no change in [3H](-)QNB binding in the corpus striatum. When measured by competitive inhibition of [3H](-)QNB binding to the longitudinal muscle of the ileum, Gpp(NH)p (100μM) caused an increase in the IC50 values of a series of agonists in a manner that was correlated with the efficacy of these compounds. The results of binding studies in NEM treated forebrain homogenates revealed an enhancement of [3H]CD binding by NEM.
AB - The regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide (NEM) was investigated using the agonist ligand, [3H] cis methyldioxolane ([3H]CD). Characterization studies on rat forebrain homogenates showed that [3H]CD binding was linear with tissue concentration and was unaffected by a change in pH form 5.5 to 8.0. The regional variation in [3H]CD binding in the rat brain correlated generally with [3H](-)3-quinuclidinyl benzilate ([3H](-)QNB) binding, although the absolute variation in binding was somewhat less. At a concentration of 100 μM, the GTP analogue, guanyl-5'-yl imidodiphosphate [Gpp(NH)p], caused a 43-77% inhibition of [3H]CD binding in the corpus striatum, ileum, and heart. The results of binding studies using several Gpp(NH)p concentrations demonstrated that the potency of this guanine nucleotide for inhibition of [3H]CD binding was greater in the heart than in the ileum. In contrast to its effects on [3H]CD binding, Gpp(NH)p caused an increase in [3H](-)QNB binding in the heart and ileum and no change in [3H](-)QNB binding in the corpus striatum. When measured by competitive inhibition of [3H](-)QNB binding to the longitudinal muscle of the ileum, Gpp(NH)p (100μM) caused an increase in the IC50 values of a series of agonists in a manner that was correlated with the efficacy of these compounds. The results of binding studies in NEM treated forebrain homogenates revealed an enhancement of [3H]CD binding by NEM.
UR - http://www.scopus.com/inward/record.url?scp=0019271766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019271766&partnerID=8YFLogxK
U2 - 10.1002/jss.400140204
DO - 10.1002/jss.400140204
M3 - Article
C2 - 7230804
AN - SCOPUS:0019271766
SN - 0730-2312
VL - 14
SP - 149
EP - 162
JO - Journal of Supramolecular and Cellular Biochemistry
JF - Journal of Supramolecular and Cellular Biochemistry
IS - 2
ER -